Raf阻害化合物およびその使用法 - VentiRx Pharmaceuticals,Inc.

Title:

Raf阻害化合物およびその使用法

Document Type and Number:

Japanese Patent JP2010502650

Kind Code:

A

Abstract:

Compounds of Formulas (I), (IIA) and (IIIA) are useful for inhibiting Raf kinase and for treating disorders mediated thereby. Methods of using compounds of Formulas (I), (IIA) and (IIIA) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

More Like This:

JP2000516593	[Title of the Invention] Selective β used for the treatment of diabetes and obesity Bottom 3 Substituted sulfonamide as an agonist
JPS5817759	[Title of the Invention] 1 and 1-Di substitution-Dihydrofloro [ 1 and 3-] [3 and 4-b] quinoxaline 4, 9-dioxide
JP4710445	Pharmaceutical composition

Inventors:

Buck Melter, Alexandre Jay.
Rishicatos, Joseph P.
Miknis, Greg
Len, lee
Wenglow Sky, Stephen Mark
Last, bryson

Application Number:

JP2009526936A

Publication Date:

January 28, 2010

Filing Date:

August 31, 2007

Export Citation:

Click for automatic bibliography generation Help

Assignee:

VentiRx Pharmaceuticals,Inc.

International Classes:

C07D491/048; A61K31/4355; A61K31/444; A61K31/506; A61P1/16; A61P3/10; A61P5/00; A61P7/02; A61P9/00; A61P9/04; A61P9/08; A61P9/10; A61P17/00; A61P17/02; A61P17/06; A61P19/02; A61P19/08; A61P21/04; A61P25/00; A61P25/02; A61P25/06; A61P25/14; A61P25/16; A61P25/28; A61P29/00; A61P31/00; A61P31/12; A61P35/00; A61P35/02; A61P37/04; A61P37/06; A61P37/08; A61P39/02; A61P43/00; C07B61/00

Attorney, Agent or Firm:

Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita

Previous Patent: JP2010502649

Next Patent: セリン−トレオニンタンパク質キナーゼおよびＰＡＲＰ調節因子